Researchers have analyzed the billions of genes that code the antibodies in a system that allows the responses to individual benign intestinal microbes to be understood
University of California - San Diego | Jul 01, 2020
Used as a noninvasive diagnostic tool, it might help patients with common nonalcoholic fatty liver disease avoid one of its deadly, progressive complications
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.